ArticleHead & neck2026
Does Modified 5-Item Frailty Index Correlate With Survival in Oropharyngeal Squamous Cell Carcinoma?
Article in Head & neck, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Biologically adaptive radiotherapy for oropharyngeal Cancer (BARitOne): An R-IDEAL stage 2a-2b technical optimisation, feasibility, and safety study - Study protocol.Clinical and translational radiation oncology · 2026Article
- Modified 5-Item Frailty Index Is Associated with Postoperative Delirium but Not Survival in Patients Undergoing Surgery for Oral Squamous Cell Carcinoma.Diagnostics (Basel, Switzerland) · 2026Article
- Does Modified 5-Item Frailty Index Correlate With Survival in Oropharyngeal Squamous Cell Carcinoma?Head & neck · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
introductionOropharyngeal squamous cell cancer (OPSCC) is a common subtype of head and neck cancer. It is generally stratified into high, intermediate, and low risk prognostic groups on the basis of HPV (human papillomavirus) status and smoking history (Ang risk stratification). Frailty has been shown to have a negative survival effect in head and neck cancer. The effect of frailty on survival in OPSCC is unknown. The aim of this study was to explore overall survival (OS) and disease-specific survival (DSS) in OPSCC based on the modified 5-item frailty index (mFI-5).
methodsThis was a retrospective cohort study of patients diagnosed with OPSCC in the West of Scotland. The mFI-5 is a validated score that categorizes patients according to their level of frailty. Univariate and multivariate survival analyses were performed.
resultsOne thousand and one patients with OPSCC diagnosed between 2012 and 2020 were identified. The median OS was shortened in both the 'Moderately Frail' (39 months) and 'Severely Frail' groups (11 months) compared with the 'Not Frail' group (82 months) (p < 0.001). DSS was shorter in the'Severely Frail' group (16 months) compared with the'Moderately Frail' group (66 months) (p < 0.001). However, after adjustment for other characteristics including HPV and PS (World Health Organization/Eastern Cooperative Oncology Group Performance Status), frailty was not significant on multivariate analysis.
conclusionSurvival in patients with OPSCC decreases significantly with increasing frailty as measured by the mFI-5. However, PS and HPV status are better predictors of OS and DSS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.